These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17369054)

  • 1. In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease.
    Smith KD; Kallhoff V; Zheng H; Pautler RG
    Neuroimage; 2007 May; 35(4):1401-8. PubMed ID: 17369054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased axonal transport rates in the Tg2576 APP transgenic mouse: improvement with the gamma-secretase inhibitor MRK-560 as detected by manganese-enhanced MRI.
    Wang FH; Appelkvist P; Klason T; Gissberg O; Bogstedt A; Eliason K; Martinsson S; Briem S; Andersson A; Visser SA; Ivarsson M; Lindberg M; Agerman K; Sandin J
    Eur J Neurosci; 2012 Nov; 36(9):3165-72. PubMed ID: 22958226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R-flurbiprofen improves axonal transport in the Tg2576 mouse model of Alzheimer's disease as determined by MEMRI.
    Smith KD; Paylor R; Pautler RG
    Magn Reson Med; 2011 May; 65(5):1423-9. PubMed ID: 21500269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired JIP3-dependent axonal lysosome transport promotes amyloid plaque pathology.
    Gowrishankar S; Wu Y; Ferguson SM
    J Cell Biol; 2017 Oct; 216(10):3291-3305. PubMed ID: 28784610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between a MAPT variant causing frontotemporal dementia and mutant APP affects axonal transport.
    Adalbert R; Milde S; Durrant C; Ando K; Stygelbout V; Yilmaz Z; Gould S; Brion JP; Coleman MP
    Neurobiol Aging; 2018 Aug; 68():68-75. PubMed ID: 29729423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative in vivo measurement of early axonal transport deficits in a triple transgenic mouse model of Alzheimer's disease using manganese-enhanced MRI.
    Kim J; Choi IY; Michaelis ML; Lee P
    Neuroimage; 2011 Jun; 56(3):1286-92. PubMed ID: 21338698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.
    Stokin GB; Lillo C; Falzone TL; Brusch RG; Rockenstein E; Mount SL; Raman R; Davies P; Masliah E; Williams DS; Goldstein LS
    Science; 2005 Feb; 307(5713):1282-8. PubMed ID: 15731448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease.
    Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I
    Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new hypothesis for early pathogenesis in Alzheimer's disease: impaired axonal transport mechanism].
    Zhu YB; Lu PH; Sheng ZH
    Sheng Li Ke Xue Jin Zhan; 2008 Jan; 39(1):5-9. PubMed ID: 18357680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
    Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E
    Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.
    van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF
    Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: an intracellular movement disorder?
    Zhu X; Moreira PI; Smith MA; Perry G
    Trends Mol Med; 2005 Sep; 11(9):391-3. PubMed ID: 16087404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
    Götz J; Ittner LM; Kins S
    J Neurochem; 2006 Aug; 98(4):993-1006. PubMed ID: 16787410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of axonal transport using MRI: aging and Alzheimer's disease.
    Minoshima S; Cross D
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S89-92. PubMed ID: 18204931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aβ secretion and plaque formation depend on autophagy.
    Nilsson P; Loganathan K; Sekiguchi M; Matsuba Y; Hui K; Tsubuki S; Tanaka M; Iwata N; Saito T; Saido TC
    Cell Rep; 2013 Oct; 5(1):61-9. PubMed ID: 24095740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patients.
    Hosono-Fukao T; Ohtake-Niimi S; Hoshino H; Britschgi M; Akatsu H; Hossain MM; Nishitsuji K; van Kuppevelt TH; Kimata K; Michikawa M; Wyss-Coray T; Uchimura K
    Am J Pathol; 2012 May; 180(5):2056-67. PubMed ID: 22429964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin.
    Haugabook SJ; Le T; Yager D; Zenk B; Healy BM; Eckman EA; Prada C; Younkin L; Murphy P; Pinnix I; Onstead L; Sambamurti K; Golde TE; Dickson D; Younkin SG; Eckman CB
    FASEB J; 2001 Jan; 15(1):16-18. PubMed ID: 11099491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.